adverse-event

Documents about adverse-event

• Emergency Pharmacist Safety Study#801844ClinicalTrials.gov
• Adverse events of romidepsin versus tucidinostat for peripheral T-cell lymphoma: a pharmacovigilance study using the Japanese adverse drug event report database#223135OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Disproportionality analysis of sex-stratified adverse event signals in growth impairment: Insights from the FDA adverse event reporting system.#388720NCBI PubMed Central
• Adverse Reactions Following COVID-19 Vaccination Among Ecuadorian Healthcare Workers#911996ClinicalTrials.gov
• Enhanced Adverse-Event Detection and Drug-Event Relation Extraction from Clinical Notes#264612bioRxiv / medRxiv
• Immune-Related Adverse Events and Associated Biomarkers in Patients Receiving Cancer Immunotherapy#417538ClinicalTrials.gov
• Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database.#193619NCBI PubMed Central
• Comprehensive analysis of adverse event profile changes with pertuzumab addition to trastuzumab‐based breast cancer therapy: Disproportionality analysis using VigiBase#194767OKAYAMA UNIVERSITY SCIENTIFIC ACHIEVEMENT REPOSITORY
• Evaluating ActionADE on Adverse Drug Event Due to Non-Adherence#847481ClinicalTrials.gov
• Evaluating ActionADE in Reducing Adverse Drug Reactions#883572ClinicalTrials.gov
• Preventing Medication Error Based on Knowledge Management Against Adverse Event#1004764Jurnal Ners
• Analysis of adverse event reporting with casimersen: a pharmacovigilance study based on the United States food and drug administration adverse event reporting system database#182800Springer Nature OA
• Large Language Models for World Health Organization-Uppsala Monitoring Centre Drug-Adverse Event Causality Assessment Using Food and Drug Administration Adverse Event Reporting System Cases: Comparative Performance Study.#395989NCBI PubMed Central
• An evolutionary approach to realism-based adverse event representations#709775PhilArchive
• 21 U.S.C. § 355b — Adverse-event reporting#577364US Code (LII)
• Metabolomic and Lipidomic Analysis Predicts Immunotherapy-related Adverse Events in Gastric Cancer Patients#184869ClinicalTrials.gov
• Preventing Adverse Drug Events With PatientSite#878607ClinicalTrials.gov
• Post-marketing Safety Surveillance of Breviscapine Powder-Injection : a Registry Study#992034ClinicalTrials.gov
• Impact of Clinical Pharmacist on Adverse Drug Events in Older Adults#885594ClinicalTrials.gov
• National Vaccine Adverse Event Reporting Survey and Etiology#127661ClinicalTrials.gov
• Sustained Virological Suppression and Improvement of Adverse Events of Switching to Raltegravir Study#871600ClinicalTrials.gov
• Treatment of Immune-related Adverse Events Refractory to Standard Therapy and Associated Changes in Immunophenotype#905482ClinicalTrials.gov
• Baseline Concentration of Direct Oral Anticoagulant and Incidence of Adverse Event Measure And See (MAS)#811902ClinicalTrials.gov
• Teclistamab-associated adverse events: a disproportionality analysis of the FDA adverse event reporting system.#976664PubMed
• Development of an adverse drug event network to predict drug toxicity#179438HAL (France)
• The Immune Assessment of PD-1 Antibody Therapy in Tumor#366588ClinicalTrials.gov
• Impact on the Adverse Event (AE) Incidence of Two Types of Experience Feedback on AE Analyzed During Local Morbidity Mortality Reviews#802895ClinicalTrials.gov
• Delirium-related adverse events and malpractice claims in Japan: an exploratory comparative analysis of national adverse event data and closed claims.#439163NCBI PubMed Central
• Safety of RIV4 Versus IIV4 in Pregnant Women#174971ClinicalTrials.gov
• Simultaneous RZV and aIIV4 Vaccination#377287ClinicalTrials.gov
• Adverse event reporting and regulatory analysis of pediatric cardiac assist devices.#452962NCBI PubMed Central
• Adverse events in different administration routes of Edaravone: A pharmacovigilance study based on the FDA adverse event reporting system#10246PLOS
• AOP-helpFinder 2.0: Integration of an event-event searches module#226940HAL (France)
• Adverse Event Scale in Patients With Epilepsy (aEscape) - A European Survey for Physicians With Epilepsy Patients#868296ClinicalTrials.gov
• Active Surveillance Reporting to Identify Adverse Events Following Chiropractic Care in Older Adults#874383ClinicalTrials.gov
• Plateletcrit as Risk Factor of Major Adverse Cardiac Event in Elderly Patient with Acute Coronary Syndrome#930437Acta Interna: The Journal of Internal Medicine
• Comparative Study of Tranexamic Acid Dosing in Cardiac Surgery#806425ClinicalTrials.gov
• Preventive Effect of EGF Cream for Cutaneous Adverse Event of EGFR Inhibitors#893029ClinicalTrials.gov
• Pharmacokinetic Study of Therapeutic Plasma Exchange#904769ClinicalTrials.gov
• Effectiveness of a RF Sponge Detection#811802ClinicalTrials.gov
• MIST3: Active Patient Safety Reporting#992754ClinicalTrials.gov
• 21 U.S.C. § 379aa — Serious adverse event reporting for nonprescription drugs#577243US Code (LII)
• Comparing the Use of a Mobile App for Surveillance of Adverse Events Following Influenza Immunization to a Web-Based Platform#158028ClinicalTrials.gov
• Drug-associated insomnia: A pharmacovigilance study based on FDA adverse event reporting system.#122999NCBI PubMed Central
• Stockholm Acute Kidney Injury Cohort#802548ClinicalTrials.gov
• Gender Bias in the Overuse Studies Conducting in Primary Care#833497ClinicalTrials.gov
• Adverse Event Data Collection From the EUHASS Registry on Turoctocog Alfa Pegol#891479ClinicalTrials.gov
• Serum cortisol as a predictor of major adverse pulmonary event in emergency department acutely dyspneic patients#955377Koc University Digital Collections
• Comparative pharmacovigilance analysis of suicidality-related adverse events among GLP-1 and non-GLP-1 anti-obesity drugs in the FDA Adverse Event Reporting System.#193620NCBI PubMed Central
• Thymosin Alpha-1 for irAE Secondary to ICIs#850611ClinicalTrials.gov